Abstract
This chapter provides an overview of the Bayesian approach to data analysis, modeling, and statistical decision making. The topics covered go from basic concepts and definitions (random variables, Bayes’ rule, prior distributions) to various models of general use in biology (hierarchical models, in particular) and ways to calibrate and use them (MCMC methods, model checking, inference, and decision). The second half of this Bayesian primer develops an example of model setup, calibration, and inference for a physiologically based analysis of 1,3-butadiene toxicokinetics in humans.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
Note that if the data were exactly what we expected a priori, there would be not much need to improve the model.
References
Albert J (2007) Bayesian computation with R. Springer, New York
Berger JO (1985) Statistical decision theory and Bayesian analysis, 2nd edn. Springer, New York
Box GEP, Tiao GC (1973) Bayesian inference in statistical analysis. Wiley, New York
O’Hagan A (1994) Kendall’s advanced theory of statistics—volume 2B—Bayesian inference. Edward Arnold, London
Gelman A, Carlin JB, Stern HS, Rubin DB (2004) Bayesian data analysis, 2nd edn. Chapman & Hall, London
Bernardo JM, Smith AFM (1994) Bayesian theory. Wiley, New York
Press SJ (1989) Bayesian statistics: principles, models, and applications. Wiley, New York
Whittaker J (1990) Graphical models in applied multivariate statistics. Wiley, Chichester
Shafer G, Pearl J (1990) Readings in uncertain reasoning. Morgan Kaufmann, San Mateo, CA
Gelman A (2006) Multilevel (hierarchical) modeling: what it can and cannot do. Technometrics 48:432–435
Chiu WA, Bois F (2007) An approximate method for population toxicokinetic analysis with aggregated data. J Agr Biol Environ Stat 12:346–363
Pillai G, Mentre F, Steimer JL (2005) Non-linear mixed effects modeling—from methodology and software development to driving implementation in drug development science. J Pharmacokinet Pharmacodyn 32:161–183
Dunson DB (2009) Bayesian nonparametric hierarchical modeling. Biom J 51:273–284
Gosh JK, Ramamoorthi RV (2003) Bayesian non-parametrics. Springer, New York
Bigelow JL, Dunson DB (2007) Bayesian adaptive regression splines for hierarchical data. Biometrics 63:724–732
Oppenheim J, Wehner S (2010) The uncertainty principle determines the nonlocality of quantum mechanics. Science 330:1072–1074
Garthwaite PH, Kadane JB, O’Hagan A (2005) Statistical methods for eliciting probability distributions. J Am Stat Assoc 100:680–700
Jaynes ET (2003) Probability theory: the logic of science. Cambridge University Press, Cambridge
Gilks WR, Richardson S, Spiegelhalter DJ (1996) Markov Chain Monte Carlo in practice. Chapman & Hall, London
Liu JS (2001) Monte Carlo strategies in scientific computing. Springer, New York
Metropolis N, Rosenbluth AW, Rosenbluth MN, Teller AH, Teller E (1953) Equation of state calculation by fast computing machines. J Chem Phys 21:1087–1092
Hastings WK (1970) Monte Carlo sampling methods using Markov chains and their applications. Biometrika 57:97–109
Gelman A, Rubin DB (1992) Inference from iterative simulation using multiple sequences (with discussion). Stat Sci 7:457–511
Geman S, Geman D (1984) Stochastic relaxation, Gibbs distributions, and the Bayesian restoration of images. IEEE Trans Pattern Anal Mach Intell 6:721–741
Doucet A, de Freitas N, Gordon N (2001) Sequential Monte Carlo methods in practice. Springer, New York
Andrieu C, Doucet A, Holenstein R (2010) Particle Markov chain Monte Carlo methods. J R Stat Soc B 72:269–342
Smith A, Gelfand A (1992) Bayesian statistics without tears: a sampling–resampling perspective. Am Stat 46:84–88
Rubin DB (1988) Using the SIR algorithm to simulate posterior distributions. In: Bernardo JM, De Groot MH, Lindley DV, Smith AFM (eds) Bayesian Statistics 3. Oxford University Press, Oxford, pp 395–402
R Development Core Team (2010) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria
Bois FY, Maszle D (1997) MCSim: a simulation program. J Stat Software 2(9). http://www.jstatsoft.org/v02/i09
Bois FY (2009) GNU MCSim: Bayesian statistical inference for SBML-coded systems biology models. Bioinformatics 25:1453–1454
Hammitt JK, Shlyakhter AI (1999) The expected value of information and the probability of surprise. Risk Anal 19:135–152
Yokota F, Gray G, Hammitt JK, Thompson KM (2004) Tiered chemical testing: a value of information approach. Risk Anal 24:1625–1639
Kass RE, Raftery AE (1995) Bayes factors. J Am Stat Assoc 90:773–795
Green PJ (1995) Reversible jump Markov chain Monte Carlo computation and Bayesian model determination. Biometrika 82:711–732
Bois FY, Smith T, Gelman A, Chang H-Y, Smith A (1999) Optimal design for a study of butadiene toxicokinetics in humans. Toxicol Sci 49:213–224
Brochot C, Smith TJ, Bois FY (2007) Development of a physiologically based toxicokinetic model for butadiene and four major metabolites in humans: global sensitivity analysis for experimental design issues. Chem Biol Interact 167:168–183
Mezzetti M, Ibrahim JG, Bois FY, Ryan LM, Ngo L, Smith TJ (2003) A Bayesian compartmental model for the evaluation of 1,3-butadiene metabolism. J R Stat Soc C 52:291–305
Micallef S, Smith TJ, Bois FY (2002) Modelling of intra-individual and inter-individual variability in 1,3-butadiene metabolism. In: PAGE 11—annual meeting of the population approach group in Europe, Population Approach Group in Europe, Paris, ISSN 1871–6032
Ngo L, Ryan LM, Mezzetti M, Bois FY, Smith TJ (2011) Estimating metabolic rate for butadiene at steady state using a Bayesian physiologically-based pharmacokinetic model. J Environ Ecol Stat 18:131–146
Smith T, Bois FY, Lin Y-S, Brochot C, Micallef S, Kim D, Kelsey KT (2008) Quantifying heterogeneity in exposure-risk relationships using exhaled breath biomarkers for 1,3-butadiene exposures. J Breath Res 2:037018 (037010 p.)
Smith T, Lin Y-S, Mezzetti L, Bois FY, Kelsey K, Ibrahim J (2001) Genetic and dietary factors affecting human metabolism of 1,3-butadiene. Chem Biol Interact 135–136:407–428
Gelman A, Bois FY, Jiang J (1996) Physiological pharmacokinetic analysis using population modeling and informative prior distributions. J Am Stat Assoc 91:1400–1412
Bischoff KB, Dedrick RL, Zaharko DS, Longstreth JA (1971) Methotrexate pharmacokinetics. J Pharm Sci 60:1128–1133
Bois FY, Zeise L, Tozer TN (1990) Precision and sensitivity analysis of pharmacokinetic models for cancer risk assessment: tetrachloroethylene in mice, rats and humans. Toxicol Appl Pharmacol 102:300–315
Droz PO, Guillemin MP (1983) Human styrene exposure—V. Development of a model for biological monitoring. Int Arch Occup Environ Health 53:19–36
Gerlowski LE, Jain RK (1983) Physiologically based pharmacokinetic modeling: principles and applications. J Pharm Sci 72:1103–1127
Reddy M, Yang RS, Andersen ME, Clewell HJ III (2005) Physiologically based pharmacokinetic modeling: science and applications. Wiley, Hoboken, New Jersey
Racine-Poon A, Wakefield J (1998) Statistical methods for population pharmacokinetic modelling. Stat Methods Med Res 7:63–84
Lunn DJ, Best N, Thomas A, Wakefield J, Spiegelhalter D (2002) Bayesian analysis of population PK/PD models: general concepts and software. J Pharmacokinet Biopharm 29:271–307
Bois F, Jamei M, Clewell HJ (2010) PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals. Toxicology 278:256–267
Fiserova-Bergerova V (1983) Physiological models for pulmonary administration and elimination of inert vapors and gases. In: Fiserova-Bergerova F (ed) Modeling of inhalation exposure to vapors: uptake, distribution, and elimination. CRC Press, Boca Raton, FL, pp 73–100
Deurenberg P, Weststrate JA, Seidell JC (1991) Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr 65:105–141
Filser JG, Johanson G, Kessler W, Kreuzer PE, Stei P, Baur C, Csanady GA (1993) A pharmacokinetic model to describe toxicokinetic interactions between 1,3-butadiene and styrene in rats: predictions for human exposure, IARC Scientific Publication No. 127. In: Sorsa M, Pletonen K, Vainio H, Hemminki K (eds) Butadiene and styrene: assessment of health hazards, International Agency for Research on Cancer, Lyon, France
Gelman A (2006) Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper). Bayesian Anal 1:515–534
Tanner MA, Wong WH (1987) The calculation of posterior distributions by data augmentation (with discussion). J Am Stat Assoc 82:528–550
Amzal B, Bois FY, Parent E, Robert CP (2006) Bayesian optimal design via interacting MCMC. J Am Stat Assoc 101:773–785
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Bois, F.Y. (2013). Bayesian Inference. In: Reisfeld, B., Mayeno, A. (eds) Computational Toxicology. Methods in Molecular Biology, vol 930. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-059-5_25
Download citation
DOI: https://doi.org/10.1007/978-1-62703-059-5_25
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-058-8
Online ISBN: 978-1-62703-059-5
eBook Packages: Springer Protocols